ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis

ClinicalTrials.gov ID: NCT03745651

Public ClinicalTrials.gov record NCT03745651. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 1:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE AD2) - A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis

Study identification

NCT ID
NCT03745651
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
618 participants

Conditions and interventions

Interventions

  • Ruxolitinib cream Drug
  • Vehicle cream Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 19, 2018
Primary completion
Nov 17, 2019
Completion
Nov 8, 2020
Last update posted
Sep 27, 2023

2018 – 2020

United States locations

U.S. sites
35
U.S. states
21
U.S. cities
34
Facility City State ZIP Site status
University Of Alabama At Birmingham Birmingham Alabama 35233
Center For Dermatology Cosmetic And Laser Surgery Fremont California 94538
Marvel Clinical Research - Clinedge - PPDS Huntington Beach California 92647
Allergy And Asthma Associates Of Southern California - CRN Mission Viejo California 92691
Synexus Clinical Research US Inc. Santa Rosa Santa Rosa California 95405
Olympian Clinical Research Largo Florida 33770
San Marcus Research Clinic Inc Miami Lakes Florida 33014
Well Pharma Medical Research Corporation South Miami Florida 33143
Forward Clinical Trials Inc Tampa Florida 33624
Clinical Research Atlanta - ERN - PPDS Stockbridge Georgia 30281
Northwest Clinical Trials Clinedge Boise Idaho 83704
Randall Dermatology West Lafayette Indiana 47906
Derm Research LLC Louisville Kentucky 40217
Dermatology Specialists PSC Louisville Kentucky 40241
Michael W Simon MD Office Nicholasville Kentucky 40356
Delricht Clinical Research - Clinedge - PPDS Baton Rouge Baton Rouge Louisiana 70809
Hamzavi Dermatology Fort Gratiot Michigan 48059
Jubilee Clinical Research - BTC - PPDS Las Vegas Nevada 89106
ActivMed Practices & Research Inc Portsmouth New Hampshire 03801
Hassman Research Institute Berlin New Jersey 08009
Skin Laser and Surgery specialists of New York and New Jersey LLC Hackensack New Jersey 07601
Derm Research Center Of New York Inc Stony Brook New York 11790
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27516
Synexus Clinical Research US, Inc. - Cincinnati Cincinnati Ohio 45236
Ohio Pediatric Research Association Dayton Ohio 45414
Synexus Clinical Research US, Inc. - Anderson Anderson South Carolina 29621
International Clinical Research Tennessee LLC Murfreesboro Tennessee 37130
Epiphany Dermatology Fort Worth Fort Worth Texas 76244
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229
Center for Clinical Studies Webster Texas 77598
Tanner Clinic Layton Utah 84041
Advanced Research Institute Ogden Utah 84405
PI Coor Clinical Research LLC Burke Virginia 22015
Clinical Research Partners LLC Richmond Virginia 23220
Dermatology Specialists of Spokane Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03745651, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 27, 2023 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03745651 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →